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The cross-reacting antigenic determinant in the variant surface glycoproteins (VSGs) of Trypanosoma 
equiperdum was studied by testing the ability of VSG glycopeptides to bind heterologous anti-VSG sera. 
VSG glycopeptide purification revealed the presence of 3 oligosaccharide sidechains on the mature VSG. 
These consist of two sidechains containing only mannose and glucosamine and a third containing galactose 
and mannose (in a 5 : 1 ratio) as well as phosphorous and ethanolamine. This phosphorylated fragment 
completely blocked the binding of VSG to heterologous anti-VSG and therefore contained the cross-reacting 
determinants. 
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1. INTRODUCTION 
Antigenic variation enables the African trypano- 
somes to evade the host’s immune system. The 
phenomenon is due to the sequential expression of 
alternative variable surface glycoproteins (VSGs) 
which coat the entire surface of the parasite [ 1,2]. 
The purified VSGs derived from the same species 
of trypanosomes exhibit extensive differences in 
their amino acid composition, isoelectric points, 
N-terminal amino acid sequences [3-51 and in their 
secondary structure [6]. Even the total carbohyd- 
rate composition varies considerably among the 
different VSGs from T. brucei [7], although in T. 
equiperdum the sugar content is more constant in 
total amount (7-8%) and composition (mainly 
mannose, galactose, N-acetyl glucosamine) [5]. In 
contrast, VSGs are characterized by the presence 
of common structures which are probably impli- 
cated in the transfer and attachment of the VSGs 
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to the cell membrane. Radioimmunoassay tests 
reveal the presence of cross-reacting determinants 
[8-lo] which appear to involve carbohydrate 
moieties [l l] attached to the C-terminal amino 
acid through ethanolamine residues [12]. We have 
reported in T. equiperdum the presence of an un- 
usual phosphorylated residue located in the C- 
terminal part of the VSGs [ 131. Here, we demon- 
strate that this phosphorylated residue is located in 
a glycopeptide which contains all the cross-reacting 
determinants. 
2. MATERIALS AND METHODS 
2.1. Trypanosome and VSG purification 
Two T. equiperdum (Pasteur strain) variants 
were used: the basic antigenic type BoTat-1 
(Bordeaux-Trypanozoon-antigenic-type 1) and 
BoTat-28, a variant appearing late in a chronic 
rabbit infection. The VSGs were purified by af- 
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finity chromatography on concanavalin A-Sepha- 
rose as in [14]. 
2.2. Isolation of glycopeptides 
BoTat-1 VSG was labelled in vivo with 32P and 
purified as in [ 131. About 3000 cpm (by Cherenkov 
counting) were mixed with 20 mg BoTat-1 VSG 
and digested with 0.2 mg trypsin (TPCK, 224 
units/mg, Worthington) in 2 ml 0.05 M ammonium 
bicarbonate buffer pH 8.5 at 37°C for 45 min. 
The reaction was terminated by the addition of 
0.3 ml 1 M acetic acid. After addition of 1 g urea 
(Ultrapur, Schwartzman) the material was applied 
directly on a Bio Gel-P30 column (100-200 mesh, 
2.6 x 100 cm) equilibrated with distilled water. 
Fractions (4 ml) were collected at 12 ml/h. The 
column effluent was monitored as appropriate: 
continuously for absorption at 206 nm using a 
LKB Uvicord S, in fraction aliquots for 32P radio- 
activity counting and carbohydrate assay. The 
fractions containing “P activity were pooled, lyo- 
philized and resuspended in 1 ml 0.01 M am- 
monium bicarbonate buffer (pH 8.5). One-half 
(0.5 ml) was digested with pronase (protease from 
Streptomyces grinseus, Sigma) and the rest with 
proteinase K (E. Merck, Darmstadt) for 26 h at 
37°C (3 additions of 2 pg pronase or proteinase K 
at 0.15 and 20 h and addition at 15 h of 0.06 g 
urea). After a further addition of 0.18 g urea, both 
digests were fractioned on a Bio Gel-P4 column 
(-400 mesh 1.6 x 100 cm) equilibrated with water. 
Fractions (2 ml) were collected at 4 ml/h and the 
effluent was monitored for absorption and radio- 
activity as already described. 
2.3. Amino acid composition 
Samples were hydrolysed in sealed tubes for 24 h 
in 5.6 M HCI at 105°C under vacuum. Amino 
acids, hexosamines and ethanolamine were sepa- 
rated on a single column of DC-6A resin (Dionex 
Corporation, Sunnyvale, CA 94086) on a Beckman 
119 CL amino acid analyzer using the buffer 
system in [IS]. 
2.4. Carbohydrate analysis 
Carbohydrate was detected in the fractions with 
the phenol/sulfuric acid method -[ 161. Gas-liquid 
chromatographic analysis of neutral and 2-amino- 
2-deoxy-hexose were performed as in [17] using a 
584OA Hewlett Packard gas chromatograph equip- 
ped with a dual flame ionization detector. 
2.5. Assay of VSG cross-reacting determinants 
Heterologous inhibition radioimmunoassay was 
used to assay for the presence of VSG cross- 
reacting determinants. 
The assay was performed essentially as in [lo] 
using l-3 ng 12~I-labelled antigen, hyperimmune 
rabbit antisera raised against purified VSGs and 
sheep anti-rabbit IgG serum. Unlabelled competi- 
tors (VSG or fragments) were mixed with the anti- 
serum at 37”C, 1 h prior to the addition of the 
labelled antigen. Heterologous antisera were used 
at the concentration sufficient to precipitate -70% 
of the antigen in the absence of competitor. 
3. RESULTS 
In order to characterize the phosphorylated 
fragment and to identify the cross-reacting anti- 
genie determinants, BoTat- 1 VSG glycopeptides 
were purified and analysed for chemical composi- 
tion and cross reaction. 
3.1. Purification of BoTat-1 VSG C-terminal 
glycopeptides 
As reported [ 131, limited trypsinisation of BoTat-1 
“P-1abelled VSG (Mr 58000) results in a large N- 
terminal fragment of M, 40000 which is no longer 
labelled as determined by SDS gel electrophoresis 
and autoradiography. Thus 20 mg BoTat-1 VSG 
mixed with labelled variant glycoprotein were di- 
gested with trypsin and the resultant peptides were 
subjected to gel filtration on a Bio Gel-P30 col- 
umn. Several peaks were detected (fig.l) in par- 
ticular a large peak (A) eluting in the excluded 
Fig. 1. Purification of a tryptic phosphorylated fragment 
from BoTat-I VSG on Bio-Gel P30: (-) AZ%; 
(0 - -a 0) 32P radioactivity. 
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volume of the column and corresponding to the M, 
40000 peptide as determined by SDS gel electro- 
phoresis, and a homogeneous peak (B) of app. M, 
10000. All of the 32P radioactivity was located in 
peak B which is also characterized by the presence 
of carbohydrates. 
Peak B was further digested either with pronase 
or with proteinase K and subjected to gel filtration 
on a Bio Gel-P4 column (fig.2). There were two 
peaks (1 and 2) which always eluted in the same 
position on P4 regardless of which protease was 
used, as well as other peaks containing higher A4, 
peptides. The “P radioactivity was only detected 
in peak 2, although some label was also present in 
the higher-M pronase fragments and probably 
represents partial digestion products. 
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Fig.2. Fractionation on Bio-Gel P4 of the tryptic phos- 
phorylated fragment digested with pronase (A) or 
proteinase K (B): (- ) A20s; (o....) 32P 
radioactivity. 
3.2. Chemical composition of the glycopeptides 
The chemical composition (table 1) shows the 
presence of 2 types of glycopeptides in BoTat-1 
VSG. 
Glycopeptide 1 (Gpl) contains 2 amino acids: 
threonine and asparagine and/or aspartic acid. 
The carbohydrate moiety was found to be com- 
posed of mannose and N-acetyl glucosamine in a 
molar ratio of 5 : 2, respectively. 
Glycopeptide 2 (Gp2) contains two amino acids, 
serine and glycine which were detected in a molar 
ratio of 5 : 1, respectively. This glycopeptide was 
also characterized by the presence of phosphorus 
and ethanolamine (BtN). 
3.3. Localisation of the cross-reacting deter- 
minants within the phospho glycopeptide Gp2 
Previous competitive radioimmunoassay tests 
[lo] have shown the presence of cross-reacting 
determinants in 2 VSGs of T. equiperdum, BoTat- 1 
and BoTat-28. The different BoTat-1 VSG frag- 
ments were tested for their ability to inhibit the 
cross-reaction of “‘1-BoTat-1 VSG vs anti- 
BoTat-28. The tryptic fraction corresponding to 
peak B contained the cross-reacting determinants 
(fig.3). After pronase or proteinase K treatment, 
Table 1 
Chemical composition of the proteinase K glycopeptides 
from BoTat-1 VSG 
GP~ Gp2 
Asx 1 - 
Thr 1.5 - 
Ser 0.8 
GUY 1 
Etn + 
=P + 
Man 5 1 
Gal 5 
GlcNac 28 - 
’ The initial value was corrected for the coefficient of 
release of GlcNac in the conditions employed 
Results are expressed in molar ratio relative to Asx and 
GlcNac for Gpl and to Gly and Man for Gp2 
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Fig.3. Inhibition of the cross-reaction lZSI-BoTat-l VSG 
versus anti-BoTat-28 VSG by native BoTat-1 VSG, tryp- 
tic fragment A (A .- A) and B (O--O) and proteinase K 
glycopeptides Gpl (O--U) and Gp2 (A--A). 
only the phosphoglycopeptide Gp2 was able to in- 
hibit the heterologous reaction. Inhibition reached 
100% and the slope of the inhibition curve pro- 
duced by the glycopeptide was identical to that of 
the intact VSG. 
4. DISCUSSION ACKNOWLEDGEMENTS 
We report here an isolation procedure which 
allows the purification of 2 BoTat-1 VSG glyco- 
peptides. Chemical composition revealed the pre- 
sence of 2 types of structures. 
Glycopeptide Gpl contains a classical oligosac- 
charide sidechain composed of mannose and N- 
acetyl glucosamine in a respective molar ratio of 
5 : 2. This composition differs from the glycosyl 
sidechain in [ 181 which is located in the N-terminal 
part of BoTat-1 VSG on asparagine at position 57 
within the sequence Ala-Asn*-Ser-Thr. The lat- 
ter oligosaccharide also contains only mannose 
and N-acetyl glucosamine, but in a respective 
molar ratio of 9 : 2. This N-terminal mannose rich 
sidechain is probably involved in the agglutination 
of BoTat variants in the presence of concanavaliti 
A [14]. 
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